- Joined
- Jan 16, 2009
- Messages
- 293
- Reaction score
- 0
Dysfunction of the respiratory epithelium is the primary determinant in the mortality of CF patients. Gene therapy has been proposed as a possible means to correct the pulmonary insufficiencies caused by CF. The transfer of normal CFTR cDNA to patients with CF could BEST be accomplished by:
A. removal of specific pulmonary epithelial cells for in vitro correction, followed by subsequent reimplantation into defective lung tissue.
B. oral administration in capsule form, allowing for slow release in the gastrointestinal tract.
C. use of a replication-deficient adenovirus that allows for gene transfer in vivo.
D. intravenous injections into the pulmonary artery, allowing for a direct distribution to the capillaries and cellular tissues of the lung
Ans: C
I feel like I got lucky here, how would you go about answering this q?
A. removal of specific pulmonary epithelial cells for in vitro correction, followed by subsequent reimplantation into defective lung tissue.
B. oral administration in capsule form, allowing for slow release in the gastrointestinal tract.
C. use of a replication-deficient adenovirus that allows for gene transfer in vivo.
D. intravenous injections into the pulmonary artery, allowing for a direct distribution to the capillaries and cellular tissues of the lung
Ans: C
I feel like I got lucky here, how would you go about answering this q?